Immunomedics (IMMU) Misses Q4 EPS by 46c

August 23, 2018 4:10 PM EDT

Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.68), $0.46 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $4.27 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings